All News

A recent study reveals similar overall reintervention risks between a 52-mg levonorgestrel-releasing intrauterine system and radiofrequency endometrial ablation for treating heavy menstrual bleeding.

A recent study reveals no significant association between COVID-19 vaccination and the incidence of abnormal uterine bleeding among reproductive-aged women.

Review some of the top stories from Contemporary OB/GYN's coverage of ACOG 2024, and catch up on anything you may have missed.

A new study highlights significant levels of harassment in obstetrics and gynecology, emphasizing the urgent need for effective interventions.

An ACOG 2024 symposium highlighted how clinicians can work with patients at every life stage to address weight management, including the potential use of anti-obesity medications.

Mary Claire B. Manske, MD, discusses her findings on the unexplained increased risk of brachial plexus birth injury among Black and Hispanic infants, highlighting the need for improved prenatal care and further research.

A symposium at ACOG 2024 focused on how to boost clinician confidence when it comes to contraception education for this patient population.

Experts discuss the necessity of evolving prenatal care through innovative models to better meet patient needs and incorporate advances such as telemedicine.

Dive into the research presented by Rhonda R. Voskuhl at ACOG 2024, shedding light on the potential of estrogen receptor beta as a target to mitigate cognitive decline in postmenopausal women.

National survey data presented at ACOG 2024 shows many medical students applying for OB/GYN residencies prioritized states with abortion access.

At ACOG 2024, Monica M. Christmas, MD, FACOG, and Stephanie Faubion, MD, emphasize the importance of combating disinformation in menopause care and provide clinicians with evidence-based strategies to manage symptoms effectively.

Raanan Meyer, MD, shares the results and takeaways from his ACOG 2024 study on a 24-hour compared with 12-hour mifepristone-misoprostol regimen for second-trimester abortion, including the impact on patient satisfaction.

At the 2024 ACOG Annual Clinical & Scientific Meeting, experts emphasized the importance of equipping ob-gyns with the knowledge and tools to address sexual health issues, including hyperactive sexual desire disorder, anorgasmia, and pelvic pain.

Phase 3 data presented by JoAnn Pinkerton, MD, reveals that elinzanetant significantly improves hot flash frequency, sleep, and overall menopause quality of life, offering a promising alternative to estrogen therapy.

According to a poster presented at ACOG 2024, use of the synthetic opioid buprenorphine depressed fetal breathing in biophysical profile assessments, but had no significant impact on other factors like amniotic fluid index or fetal tone.

New ACOG 2024 data suggest SARS-CoV-2 in the early stages of pregnancy can lead to a higher likelihood of preeclampsia, as well as more severe disease.

A recent study presented at the 2024 ACOG Clinical and Scientific Meeting reveals that laparoscopic radiofrequency ablation significantly improves pregnancy outcomes for women with uterine leiomyomas.

Preventing congenital syphilis comes down to quick diagnosis and treatment of the infection in pregnancy, and the number of missed opportunities to do so in the United States continues to grow.

Leanne R. McCloskey, MD, and Weronika A. Armstrong, MD, xplore the multifaceted applications of misoprostol in obstetrics, covering protocols, safety, and the impact on birth equity from early pregnancy loss to labor induction at ACOG 2024.

A recent study suggests that higher CASP8 expression in embryos is associated with successful implantation outcomes in women of advanced maternal age, as presented at ACOG 2024.

Michelle Jacobson, MD, MHSc, FRCSC, shares critical perspectives on managing vasomotor symptoms in breast cancer patients at the recent ACOG Annual Clinical & Scientific Meeting, emphasizing the importance of tailored approaches amidst evolving treatment options and patient risks.

In a poster presented at ACOG 2024, investigators found that mean placental weight was higher in patients with asthma, and that pregnancy hormone levels do differ based on asthma status.

A recent study showcased at the 2024 ACOG Annual Clinical & Scientific Meeting unveils elinzanetant's efficacy in alleviating vasomotor symptoms, sleep disturbances, and enhancing menopause-related quality of life in postmenopausal women.

A comprehensive analysis reveals strong associations between polycystic ovary syndrome, irregular menstrual cycles, and increased risks of cardiometabolic conditions, underscoring the importance of proactive screening and intervention strategies.

Roche's innovative human papillomavirus self-collection solution offers a breakthrough in cervical cancer screening, providing accessible and reliable testing to combat underscreening rates and increase early detection.

A study highlights how having a primary care physician significantly increases the likelihood of cervical cancer screening among lesbian, gay, and bisexual cisgender women, addressing disparities exacerbated by systemic discrimination and healthcare access challenges.

Explore the latest findings revealing vaccination rates among children aged 9 to 17 years, uncovering demographic disparities and highlighting the crucial role of vaccination in combating human papillomavirus infections and related health risks.

A recent study highlights the heightened risks of maternal and neonatal morbidity and mortality associated with combined cannabis and nicotine use during pregnancy, urging further investigation into their impact on short- and long-term outcomes.

Discover how recent findings highlight the significance of echogenic masses in accurately diagnosing post-pregnancy complications, shedding light on effective management strategies and reducing the need for invasive interventions.

Review some of the top stories from the Contemporary OB/GYN website over the last week, and catch up on anything you may have missed.